Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
Glioblastoma is the most common brain malignant tumor in the adult population, and immunotherapy is playing an increasingly central role in the treatment of many cancers. Nevertheless, the search for effective immunotherapeutic approaches for glioblastoma patients continues. The goal of immunotherap...
| Published in: | Cells |
|---|---|
| Main Authors: | Bernarda Majc, Metka Novak, Nataša Kopitar-Jerala, Anahid Jewett, Barbara Breznik |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-01-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/10/2/265 |
Similar Items
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
by: Andrej Porčnik, et al.
Published: (2021-08-01)
by: Andrej Porčnik, et al.
Published: (2021-08-01)
Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches
by: Sajina Shakya, et al.
Published: (2021-05-01)
by: Sajina Shakya, et al.
Published: (2021-05-01)
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
by: Eliane Klein, et al.
Published: (2020-12-01)
by: Eliane Klein, et al.
Published: (2020-12-01)
A reference for selecting an appropriate method for generating glioblastoma organoids from the application perspective
by: Jing Liang, et al.
Published: (2024-09-01)
by: Jing Liang, et al.
Published: (2024-09-01)
Immunotherapy in Glioblastoma: An Overview of Current Status
by: Sarfraz Z, et al.
Published: (2025-07-01)
by: Sarfraz Z, et al.
Published: (2025-07-01)
Bioactive peptides from venoms against glioma progression
by: Bernarda Majc, et al.
Published: (2022-08-01)
by: Bernarda Majc, et al.
Published: (2022-08-01)
Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives
by: Niclas Skarne, et al.
Published: (2025-01-01)
by: Niclas Skarne, et al.
Published: (2025-01-01)
Glioblastoma organoid technology: an emerging preclinical models for drug discovery
by: Don Carlo Ramos Batara, et al.
Published: (2022-02-01)
by: Don Carlo Ramos Batara, et al.
Published: (2022-02-01)
Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models
by: Cátia D. Correia, et al.
Published: (2025-02-01)
by: Cátia D. Correia, et al.
Published: (2025-02-01)
Development of glioblastoma organoids and their applications in personalized therapy
by: Can Xu, et al.
Published: (2023-05-01)
by: Can Xu, et al.
Published: (2023-05-01)
Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration
by: Veronika Fedorova, et al.
Published: (2023-04-01)
by: Veronika Fedorova, et al.
Published: (2023-04-01)
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
by: Tamara T. Lah, et al.
Published: (2021-02-01)
by: Tamara T. Lah, et al.
Published: (2021-02-01)
Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications
by: Freya R. Weth, et al.
Published: (2022-12-01)
by: Freya R. Weth, et al.
Published: (2022-12-01)
Integrative multi-omic profiling of the neoantigen landscape of glioblastoma for the development of therapeutic vaccines reveals vast heterogeneity in immunogenic signatures
by: Qingtang Lin, et al.
Published: (2025-03-01)
by: Qingtang Lin, et al.
Published: (2025-03-01)
Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma
by: John Y. Rhee, et al.
Published: (2023-01-01)
by: John Y. Rhee, et al.
Published: (2023-01-01)
Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance
by: Justin Tang, et al.
Published: (2025-04-01)
by: Justin Tang, et al.
Published: (2025-04-01)
Neoadjuvant PD-1 blockade induces the autophagy of immune cells: a new target for synergistic therapy of recurrent glioblastoma
by: Zixue Xuan, et al.
Published: (2025-09-01)
by: Zixue Xuan, et al.
Published: (2025-09-01)
Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions
by: Mingming Wang, et al.
Published: (2023-05-01)
by: Mingming Wang, et al.
Published: (2023-05-01)
Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy
by: Landon Teer, et al.
Published: (2024-01-01)
by: Landon Teer, et al.
Published: (2024-01-01)
Assembly of glioblastoma tumoroids and cerebral organoids: a 3D in vitro model for tumor cell invasion
by: Jieun Kim, et al.
Published: (2025-03-01)
by: Jieun Kim, et al.
Published: (2025-03-01)
Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario
by: Andrea Bianconi, et al.
Published: (2023-05-01)
by: Andrea Bianconi, et al.
Published: (2023-05-01)
Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01)
by: Yuanyang Sun, et al.
Published: (2025-05-01)
Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
by: Maowu Fu, et al.
Published: (2025-03-01)
by: Maowu Fu, et al.
Published: (2025-03-01)
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
by: Berta Segura-Collar, et al.
Published: (2023-05-01)
by: Berta Segura-Collar, et al.
Published: (2023-05-01)
Glioblastoma: A Multidisciplinary Approach to Its Pathophysiology, Treatment, and Innovative Therapeutic Strategies
by: Felipe Esparza-Salazar, et al.
Published: (2025-08-01)
by: Felipe Esparza-Salazar, et al.
Published: (2025-08-01)
T cell-mediated tumor killing based signature to predict the prognosis and immunotherapy for glioblastoma
by: Hongchao Liu, et al.
Published: (2024-05-01)
by: Hongchao Liu, et al.
Published: (2024-05-01)
Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
by: Zide Wang, et al.
Published: (2022-10-01)
by: Zide Wang, et al.
Published: (2022-10-01)
Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions
by: Olivier Uwishema, et al.
Published: (2025-08-01)
by: Olivier Uwishema, et al.
Published: (2025-08-01)
Editorial: Improving responses to immunotherapy in glioblastoma multiforme
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)
The challenges and clinical landscape of glioblastoma immunotherapy
by: Andrew Timothy Ng, et al.
Published: (2024-12-01)
by: Andrew Timothy Ng, et al.
Published: (2024-12-01)
Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy
by: Niovi Nicolaou, et al.
Published: (2025-10-01)
by: Niovi Nicolaou, et al.
Published: (2025-10-01)
Energy Metabolism in <i>IDH1</i> Wild-Type and <i>IDH1</i>-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
by: Cornelis J.F. van Noorden, et al.
Published: (2021-03-01)
by: Cornelis J.F. van Noorden, et al.
Published: (2021-03-01)
Causes of drug resistance and glioblastoma relapses
by: A. A. Mitrofanov, et al.
Published: (2021-04-01)
by: A. A. Mitrofanov, et al.
Published: (2021-04-01)
The Interplay of Tumor Vessels and Immune Cells Affects Immunotherapy of Glioblastoma
by: Mitrajit Ghosh, et al.
Published: (2022-09-01)
by: Mitrajit Ghosh, et al.
Published: (2022-09-01)
Personalized Treatment of Glioblastoma: Current State and Future Perspective
by: Alen Rončević, et al.
Published: (2023-05-01)
by: Alen Rončević, et al.
Published: (2023-05-01)
The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01)
by: Zhaoming Song, et al.
Published: (2025-12-01)
A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
by: Megan R. Reed, et al.
Published: (2021-12-01)
by: Megan R. Reed, et al.
Published: (2021-12-01)
Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling
by: Mariangela Morelli, et al.
Published: (2024-03-01)
by: Mariangela Morelli, et al.
Published: (2024-03-01)
Advances in immunotherapy for glioblastoma multiforme
by: Ahmad Bakur Mahmoud, et al.
Published: (2022-10-01)
by: Ahmad Bakur Mahmoud, et al.
Published: (2022-10-01)
Trends in the immunotherapy for glioblastoma: A two-decade bibliometric analysis
by: Zhi Long, et al.
Published: (2025-12-01)
by: Zhi Long, et al.
Published: (2025-12-01)
Similar Items
-
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
by: Andrej Porčnik, et al.
Published: (2021-08-01) -
Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches
by: Sajina Shakya, et al.
Published: (2021-05-01) -
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
by: Eliane Klein, et al.
Published: (2020-12-01) -
A reference for selecting an appropriate method for generating glioblastoma organoids from the application perspective
by: Jing Liang, et al.
Published: (2024-09-01) -
Immunotherapy in Glioblastoma: An Overview of Current Status
by: Sarfraz Z, et al.
Published: (2025-07-01)
